Pharma Compliance CEE,Radisson Blu Hotel, Istanbul Asia, Istanbul, Turkey
Compliance Strategy for Pharma - Pharma Compliance CEE

Conference
08.00
Registration and morning refreshments
08.50
Opening remarks from the chair
09.00

Corporate governance: Achieving a culture of compliance and establishing an ethical business conduct

Corporate governance: Achieving a culture of compliance and establishing an ethical business conduct
09.30

Implementing and delivering effective training on compliance and ethics

Implementing and delivering effective training on compliance and ethics
10.00

Incentivising and compensating employees' ethical behaviour to ensure compliance

  • › Esra Korun, Legal Affairs & Compliance Lawyer, Business Area Near East (BANE), Novo Nordisk As, Turkey
Incentivising and compensating employees' ethical behaviour to ensure compliance
10.30
Speed networking and refreshment break
11.30

Cross border cooperation: Working with affiliates to develop and implement compliance programme from the ground up

  • › Andriy Kirmach, Compliance & Ethics Manager, EAME Direct Markets and CIS, Allergan Ltd, United Kingdom
Cross border cooperation: Working with affiliates to develop and implement compliance programme from the ground up
12.00

One step further towards compliance and transparency

One step further towards compliance and transparency
12.30
Lunch
13.30

Transparency and disclosure update: View from European headquarters and implications for regional teams in the CEE

Transparency and disclosure update: View from European headquarters and implications for regional teams in the CEE
14.00

The Dynamic Shift – Implementing disparate country by country compliance solutions to a single global 2 local (G2L) approach

The Dynamic Shift – Implementing disparate country by country compliance solutions to a single global 2 local (G2L) approach
14.30

Russia and CIS environment: Challenges and opportunities to build an effective compliance program

Russia and CIS environment: Challenges and opportunities to build an effective compliance program
15.00
Afternoon refreshments
15.30

Initiatives governing ethical conduct, transparency and disclosure in Turkey

Initiatives governing ethical conduct, transparency and disclosure in Turkey
16.00

Review of compliance operational realities: the Turkish regulatory and compliance context

Review of compliance operational realities: the Turkish regulatory and compliance context
16.30

PANEL: Review of MEA compliance challenges and initiatives

PANEL: Review of MEA compliance challenges and initiatives
17.00
Closing remarks from the chair
17.05
Party

Conference
08.50
Opening remarks from the chair
09.00

Challenges and considerations when implementing and maintaining an effective compliance programme in South-Eastern Europe

Challenges and considerations when implementing and maintaining an effective compliance programme in South-Eastern Europe
09.30

Are you really sure you know everything about your third parties? How to conduct effective due diligence and deal with the latest hot topics and current trends facing the pharmaceutical sector

Are you really sure you know everything about your third parties? How to conduct effective due diligence and deal with the latest hot topics and current trends facing the pharmaceutical sector
10.00

Export control and business partner screening of potential business partners

Export control and business partner screening of potential business partners
10.30
Morning refreshments
11.00
Due diligence and risk management of TPIs
11.30
PANEL: Global Anti-bribery policies, due diligence and monitoring
12.00

Ensuring compliance and minimising risk in clinical trials through implementation of effective training

Ensuring compliance and minimising risk in clinical trials through implementation of effective training
12.30
Lunch
13.30
Compliant cross boarder congress organisation
14.00

Interaction with HCPs and overcoming practical challenges in areas where corruption risk is heightened

Interaction with HCPs and overcoming practical challenges in areas where corruption risk is heightened
14.35
Close of conference

sponsors
Gold Sponsor
BMI System at Pharma Compliance CEE
Silver Sponsor
Thomson Reuters Accelus at Pharma Compliance CEE